Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin
暂无分享,去创建一个
P. Houghton | P. Gokhale | D. Epstein | N. Gibson | L. Arnold | Christine Mantis | A. Crew | R. Wild | J. Pachter | S. Bhagwat | Yan Yao | Jennifer Kahler | A. Cooke | M. Bittner | Jennifer E. Workman | L. Dudkin | Lorina Dudkin